Literature DB >> 1872806

Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis.

R A Hawkins1, J Jessy.   

Abstract

1. It has been established that chronic hyperammonaemia, whether caused by portacaval shunting or other means, leads to a variety of metabolic changes, including a depression in the cerebral metabolic rate of glucose (CMRGlc) increased permeability of the blood-brain barrier to neutral amino acids, and an increase in the brain content of aromatic amino acids. The preceding paper [Jessy, DeJoseph & Hawkins (1991) Biochem. J. 277, 693-696] showed that the depression in CMRGlc caused by hyperammonaemia correlated more closely with glutamine, a metabolite of ammonia, than with ammonia itself. This suggested that ammonia (NH3 and NH4+) was without effect. The present experiments address the question whether ammonia, in the absence of net glutamine synthesis, induces any of the metabolic symptoms of cerebral dysfunction associated with hyperammonaemia. 2. Small doses of methionine sulphoximine, an inhibitor of glutamine synthetase, were used to raise the plasma ammonia levels of normal rats without increasing the brain glutamine content. These hyperammonaemic rats, with plasma and brain ammonia levels equivalent to those known to depress brain function, behaved normally over 48 h. There was no depression of cerebral energy metabolism (i.e. the rate of glucose consumption). Contents of key intermediary metabolites and high-energy phosphates were normal. Neutral amino acid transport (tryptophan and leucine) and the brain contents of aromatic amino acids were unchanged. 3. The data suggest that ammonia is without effect at concentrations less than 1 mumol/ml if it is not converted into glutamine. The deleterious effect of chronic hyperammonaemia seems to begin with the synthesis of glutamine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872806      PMCID: PMC1151300          DOI: 10.1042/bj2770697

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  EFFECT OF AN INHIBITOR OF GLUTAMINE SYNTHESIS (METHIONINE SULFOXIMINE) ON AMMONIA TOXICITY AND METABOLISM.

Authors:  K S WARREN; S SCHENKER
Journal:  J Lab Clin Med       Date:  1964-09

Review 2.  Effects of NH4+ on the function of the CNS.

Authors:  W Raabe
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Studies on brain metabolism: The metabolism of glutamic acid in brain.

Authors:  H Weil-Malherbe
Journal:  Biochem J       Date:  1936-04       Impact factor: 3.857

4.  Hyperammonaemia causes many of the changes found after portacaval shunting.

Authors:  J Jessy; A M Mans; M R DeJoseph; R A Hawkins
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  Significance of glutamic acid for the metabolism of nervous tissue.

Authors:  H WEIL-MALHERBE
Journal:  Physiol Rev       Date:  1950-10       Impact factor: 37.312

6.  The influence of ketamine on regional brain glucose use.

Authors:  D W Davis; A M Mans; J F Biebuyck; R A Hawkins
Journal:  Anesthesiology       Date:  1988-08       Impact factor: 7.892

7.  Glutamine--a major substrate for nerve endings.

Authors:  H F Bradford; H K Ward; A J Thomas
Journal:  J Neurochem       Date:  1978-06       Impact factor: 5.372

8.  Glucose consumption decreases throughout the brain only hours after portacaval shunting.

Authors:  M R DeJoseph; R A Hawkins
Journal:  Am J Physiol       Date:  1991-04

9.  Hyperammonaemia depresses glucose consumption throughout the brain.

Authors:  J Jessy; M R DeJoseph; R A Hawkins
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

10.  L-glutamate stimulates the efflux of newly taken up glutamine from astroglia but not from synaptosomes of the rat.

Authors:  J Albrecht
Journal:  Neuropharmacology       Date:  1989-08       Impact factor: 5.250

View more
  18 in total

Review 1.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

2.  NMDA receptor antagonists prevent acute ammonia toxicity in mice.

Authors:  C Hermenegildo; G Marcaida; C Montoliu; S Grisolía; M D Miñana; V Felipo
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

Review 3.  Effects of hyperammonemia on brain protein kinase C substrates.

Authors:  E Grau; G Marcaida; C Montoliu; M D Miñana; S Grisolía; V Felipo
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

Review 4.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

Review 5.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

6.  Astrocytes and the entry of circulating ammonia into the brain: effect of fluoroacetate.

Authors:  J C Szerb; I M Redondo
Journal:  Metab Brain Dis       Date:  1993-12       Impact factor: 3.584

7.  High ammonia diet: its effect on the glial fibrillary acidic protein (GFAP).

Authors:  G Bodega; I Suárez; M C Boyano; M Rubio; R M Villalba; E Arilla; L González-Guijarro; B Fernández
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 8.  Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Res       Date:  2013-01-01       Impact factor: 3.996

9.  Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.

Authors:  K Suzuki; N Matsuo; T Moriguchi; N Takeyama; Y Kitazawa; T Tanaka
Journal:  Metab Brain Dis       Date:  1992-06       Impact factor: 3.584

10.  Effects of methionine sulphoximine treatment on renal amino acid and ammonia metabolism in rats.

Authors:  S Heeneman; C H Dejong; N E Deutz
Journal:  Pflugers Arch       Date:  1994-07       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.